Aernoud Fiolet

138 Chapter 5 Erik Boersma, PhD (Statistician) Christopher Reid, MD Melanie Greenland (Non-voting independent statistician) Data Management and Statistical Analysis School of Population and Global Health, University of Western Australia, Perth, Australia. Charley A. Budgeon, PhD Unblinded party for dispense of trial medication: Michiel Duyvendak, Pharm PhD, for The Netherlands Karen Doherty, for Australia Clinical Coordinating Center, The Netherlands Dutch Network for Cardiovascular Research (WCN), Utrecht, The Netherlands Operational Leadership: Astrid Schut Project manager: Marjelle T. van Leeuwen Data managers: Ingrid Groenenberg and Glentino Rodrigues Medical Monitors: Aernoud T.L. Fiolet, Max J.M. Silvis and Tim de Vries Site Monitors: Petra Bunschoten and Wendy A. Tousain Clinical Coordinating Center, Australia Health Research Institute Western Australia, Perth, Australia Key staff for trial medication supply and data capture: Louise Nidorf, Penny Buczec, Denny Craig, and Karen Youl Cross site Monitoring: Marjelle T. van Leeuwen, Aernoud T.L. Fiolet, and Astrid Schut Study Site (number of participants randomized) and Investigators Australia (1904) Patients were recruited in 13 clinical practices (Study Sites) operating within GenesisCare, a national organisation delivering cardiology care in Australia. GenesisCare has core-urban and rural sites. The contributing investigators recruited from multiple locations. S.M. Nidorf (304), X.F. Xu (263), M.A. Ireland (253), D. Latchem (197), A. Whelan (176), R. Hendriks (171), P. Salkani (145), I.W. Tan (96), A.G Thompson (98), A.M. Morton (76), B.E Hockings (74), P.L. Thompson (36), B. King (15) The Netherlands (3618):